{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:19:56Z","timestamp":1771654796869,"version":"3.50.1"},"reference-count":60,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T00:00:00Z","timestamp":1685664000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["por-journal.com"],"crossmark-restriction":true},"short-container-title":["Pathol. Oncol. Res."],"abstract":"<jats:p><jats:bold>Introduction:<\/jats:bold> Acquired factor V inhibitor (AFVI) is a rare autoimmune bleeding disorder. The treatment of AFVI is challenging, and patients often require both bleeding control and inhibitor eradication.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> We conducted a retrospective analysis of the medical records of a 35-year-old Caucasian woman who presented with severe AFVI-induced bleeding and subsequent immunosuppressive therapy.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> To provide haemostasis, rFVIIa was given with good efficacy. The patient was treated with various combinations of immunosuppressive regimens over the course of 2.5\u00a0years, including plasmapheresis plus immunoglobulins, dexamethasone + rituximab, cyclophosphamide + dexamethasone + rituximab + cyclosporine, cyclosporin + sirolimus + cyclophosphamide + dexamethasone, bortezomib + sirolimus + methylprednisolone, and sirolimus + mycophenolate mofetil. Although these treatment modalities resulted in intermittent partial reversals of AFVI over 2.5\u00a0years, eventually the inhibitor became therapy-resistant. However, following the discontinuation of all immunosuppressive therapy, the patient experienced a partial spontaneous remission, which was followed by a pregnancy. During the pregnancy, the FV activity increased to 54% and the coagulation parameters returned to normal levels. The patient underwent Caesarean section without any bleeding complications and delivered a healthy child.<\/jats:p><jats:p><jats:bold>Discussion:<\/jats:bold> The use of an activated bypassing agent for bleeding control is effective in patients with severe AFVI. The presented case is unique because the treatment regimens included multiple combinations of immunosuppressive agents. This demonstrates that AFVI patients may undergo spontaneous remission even after multiple courses of ineffective immunosuppressive protocols. Additionally, pregnancy-associated improvement of AFVI is an important finding that warrants further investigation.<\/jats:p>","DOI":"10.3389\/pore.2023.1611250","type":"journal-article","created":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T04:30:38Z","timestamp":1685680238000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Delayed spontaneous remission of acquired factor V inhibitor refractory to immunosuppressive therapy with pregnancy-associated improvement"],"prefix":"10.3389","volume":"29","author":[{"given":"Andrea","family":"Cegl\u00e9di","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00e1nos","family":"Dolgos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00f3nika","family":"Fekete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00e1szl\u00f3","family":"Gopcsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"V\u00e1rkonyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Be\u00e1ta","family":"Vilimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G\u00e1bor","family":"Mikala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imre","family":"Bod\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,6,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/MBC.0000000000000581","article-title":"Acquired factor V deficiency in a patient with a urinary tract infection presenting with haematuria followed by multiple haemorrhages with an extremely low level of factor V inhibitor: A case report and review of the literature","volume":"28","author":"Wang","year":"2017","journal-title":"Blood Coagul Fibrinolysis"},{"key":"B2","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1183\/09031936.93.03010109","article-title":"Acquired factor V deficiency in a patient with pulmonary tuberculosis","volume":"3","author":"Aliaga","year":"1990","journal-title":"Eur Respir J"},{"key":"B3","doi-asserted-by":"publisher","first-page":"e160","DOI":"10.1111\/hae.13492","article-title":"The interaction of factor V and tissue factor pathway inhibitor in a myeloma patient with acquired factor V deficiency","volume":"24","author":"De Maertelaere","year":"2018","journal-title":"Haemophilia"},{"key":"B4","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1097\/BCR.0b013e3181d0f5b4","article-title":"Acquired factor V deficiency associated with exposure to bovine thrombin in a burn patient","volume":"31","author":"Foster","year":"2010","journal-title":"J Burn Care Res"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.thromres.2018.01.045","article-title":"Acquired factor V deficiency in a patient with myeloma and amyloidosis","volume":"164","author":"Quek","year":"2018","journal-title":"Thromb Res"},{"key":"B6","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1097\/MBC.0000000000001009","article-title":"Acquired factor V inhibitor in the setting of coronavirus disease 2019 infection","volume":"32","author":"Bennett","year":"2021","journal-title":"Blood Coagul Fibrinolysis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/(SICI)1096-8652(199608)52:4<332:AID-AJH22>3.0.CO;2-E","article-title":"Acquired factor V inhibitor in a patient with acquired human immunodeficiency syndrome","volume":"52","author":"Brickner","year":"1996","journal-title":"Am J Hematol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1002\/ccr3.3452","article-title":"An acquired factor V inhibitor induced uncontrolled bleeding in a postsurgery patient","volume":"9","author":"Bruna","year":"2021","journal-title":"Clin Case Rep"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e9481","DOI":"10.7759\/cureus.9481","article-title":"Acquired factor V inhibitor after antibiotic therapy: A clinical case report and review of the literature","volume":"12","author":"Chartier","year":"2020","journal-title":"Cureus"},{"key":"B10","first-page":"921","article-title":"Acquired factor V inhibitor in a patient with gingival squamous cell cancer and tuberculosis","volume":"6","author":"Chenthilmurugan","year":"2008","journal-title":"Clin Adv Hematol Oncol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1055\/s-0041-1735452","article-title":"Acquired factor V inhibitor after coronavirus disease 2019 (COVID-19)","volume":"48","author":"Chiurazzi","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"B12","doi-asserted-by":"publisher","first-page":"e636","DOI":"10.1111\/hae.14374","article-title":"Acquired factor V inhibitor presenting as life threatening bleeding after initiation of apixaban","volume":"27","author":"Fortuna","year":"2021","journal-title":"Haemophilia"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1007\/s00277-018-3348-z","article-title":"A rare case of an acquired factor V inhibitor in a patient with myelodysplastic syndrome during azacitidine treatment","volume":"97","author":"Fujita","year":"2018","journal-title":"Ann Hematol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/ccr3.3586","article-title":"A rare case of acquired factor V inhibitor, during treatment with dabigatran for chronic atrial fibrillation, successfully treated with bypassing agents","volume":"9","author":"Giuffrida","year":"2021","journal-title":"Clin Case Rep"},{"key":"B15","doi-asserted-by":"publisher","first-page":"e12708","DOI":"10.7759\/cureus.12708","article-title":"Development of acquired factor V inhibitor after surgical procedure without the use of fibrin tissue adhesives: A case report","volume":"13","author":"Hirata","year":"2021","journal-title":"Cureus"},{"key":"B16","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1016\/j.amjmed.2005.01.049","article-title":"Acquired factor V inhibitor: A common and avoidable complication of topical bovine thrombin application","volume":"118","author":"Kirkeby","year":"2005","journal-title":"Am J Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000496080","article-title":"Acquired factor V inhibitor with symptoms and titer of inhibitor differences: Report of two cases","volume":"141","author":"Li","year":"2019","journal-title":"Acta Haematol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1111\/j.1365-2257.2006.00873.x","article-title":"Spontaneous resolution of acquired factor V inhibitor associated with ovarian carcinoma","volume":"29","author":"Maughan","year":"2007","journal-title":"Int J Lab Hematol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1159\/000502730","article-title":"Successful management of acquired factor V inhibitor by monitoring factor V activity, antigen, and inhibitor values during immunosuppressive therapy","volume":"143","author":"Mihara","year":"2020","journal-title":"Acta Haematol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"91","DOI":"10.2169\/internalmedicine.7173-21","article-title":"Acquired factor V inhibitor complicated with immune thrombocytopenia","volume":"61","author":"Mima","year":"2022","journal-title":"Intern Med"},{"key":"B21","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.thromres.2018.09.052","article-title":"Acquired factor V inhibitor-related severe bleeding due to unformed prothrombinase complex","volume":"171","author":"Mitsuhashi","year":"2018","journal-title":"Thromb Res"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1111\/j.1365-2044.2009.05945.x","article-title":"Acquired factor V inhibitor in a critically ill patient","volume":"64","author":"Morris","year":"2009","journal-title":"Anaesthesia"},{"key":"B23","doi-asserted-by":"publisher","first-page":"393","DOI":"10.2169\/internalmedicine.9150-17","article-title":"High titer of acquired factor V inhibitor presenting with a pseudo-deficiency of multiple coagulation factors","volume":"57","author":"Nakata","year":"2018","journal-title":"Intern Med"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.2169\/internalmedicine.49.4042","article-title":"Acquired factor V inhibitor in a patient with a mechanical aortic valve under warfarin therapy","volume":"49","author":"Nozu","year":"2010","journal-title":"Intern Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.tracli.2021.01.004","article-title":"Acquired factor V inhibitor: Success of steroids in a patient with primary sclerosing cholangitis, ulcero haemorragic rectocolitis, biological Biermer's disease","volume":"28","author":"Pineau-Vincent","year":"2021","journal-title":"Transfus Clin Biol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1159\/000502406","article-title":"Acquired factor V inhibitor with hemorrhagic symptoms after prasugrel hydrochloride treatment","volume":"143","author":"Sakatoku","year":"2020","journal-title":"Acta Haematol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/MBC.0000000000000059","article-title":"Acquired factor V inhibitor in a woman following aortic aneurysm surgery","volume":"25","author":"Siekanska-Cholewa","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1111\/hae.12280","article-title":"Acquired factor V deficiency in a patient without evidence of a classical inhibitor","volume":"20","author":"Sosa","year":"2014","journal-title":"Haemophilia"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1007\/s00277-019-03638-6","article-title":"Acquired factor V inhibitor after antibiotic treatment in a patient with pneumonia: A case report","volume":"98","author":"Taniwaki","year":"2019","journal-title":"Ann Hematol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1177\/1076029606293438","article-title":"Spectrum of bleeding in acquired factor V inhibitor: A summary of 33 cases","volume":"12","author":"Wiwanitkit","year":"2006","journal-title":"Clin Appl Thromb Hemost"},{"key":"B31","doi-asserted-by":"publisher","first-page":"2663","DOI":"10.2169\/internalmedicine.7453-21","article-title":"Acquired coagulation factor V inhibitor that was successfully treated with oral corticosteroid therapy","volume":"60","author":"Yokota","year":"2021","journal-title":"Intern Med"},{"key":"B32","doi-asserted-by":"publisher","first-page":"100058","DOI":"10.1016\/j.tru.2021.100058","article-title":"Coagulation factor V inhibitors, a review of the case report literature","volume":"4","author":"Wada","year":"2021","journal-title":"Thromb Update"},{"key":"B33","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1160\/th08-11-0767","article-title":"Acquired factor V inhibitor. A problem-based systematic review","volume":"101","author":"Ang","year":"2009","journal-title":"Thromb Haemost"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.11406\/rinketsu.55.2311","article-title":"Development of asymptomatic acquired factor V inhibitor after the administration of antibiotics","volume":"55","author":"Kinjo","year":"2014","journal-title":"Rinsho Ketsueki"},{"key":"B35","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/bjh.13438","article-title":"Acquired factor V deficiency in myeloproliferative neoplasms: A mayo clinic series of 33 patients","volume":"171","author":"Ashrani","year":"2015","journal-title":"Br J Haematol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1983","DOI":"10.1182\/blood.2022016873","article-title":"Combined immunosuppression for acquired hemophilia A: CyDRi is a highly effective low-toxicity regimen","volume":"140","author":"Simon","year":"2022","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/s0022-2143(99)90062-8","article-title":"Clinical and laboratory manifestations of anti-factor V antibodies","volume":"133","author":"Ortel","year":"1999","journal-title":"J Lab Clin Med"},{"key":"B38","doi-asserted-by":"publisher","first-page":"4657501","DOI":"10.1155\/2021\/4657501","article-title":"Autoimmune factor V deficiency that took 16 Years to diagnose due to pseudodeficiency of multiple coagulation factors","volume":"2021","author":"Kato","year":"2021","journal-title":"Case Rep Med"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1055\/s-0037-1615962","article-title":"Fine mapping of inhibitory anti-factor V antibodies using factor V C2 domain mutants. Identification of two antigenic epitopes involved in phospholipid binding","volume":"85","author":"Izumi","year":"2001","journal-title":"Thromb Haemost"},{"key":"B40","doi-asserted-by":"publisher","first-page":"4188","DOI":"10.1182\/blood.v91.11.4188.411k33_4188_4196","article-title":"Inhibitory anti-factor V antibodies bind to the factor V C2 domain and are associated with hemorrhagic manifestations","volume":"91","author":"Ortel","year":"1998","journal-title":"Blood"},{"key":"B41","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1177\/1076029607308866","article-title":"Further removal of factor v related antigen from bovine thrombin by utilizing a membrane-filtration step","volume":"14","author":"Terrab","year":"2008","journal-title":"Clin Appl Thromb Hemost"},{"key":"B42","first-page":"504","article-title":"Autoimmune hemolytic anemia associated with benign ovarian cyst: A case report and review of literature","volume":"57","author":"Agarwal","year":"2003","journal-title":"Indian J Med Sci"},{"key":"B43","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1136\/jcp.21.5.626","article-title":"Autoimmune haemolytic anaemia associated with ovarian dermoid cyst","volume":"21","author":"Baker","year":"1968","journal-title":"J Clin Pathol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1093\/ajcp\/105.5.567","article-title":"Ovarian dermoid cyst-associated autoimmune hemolytic anemia: A case report with emphasis on pathogenic mechanisms","volume":"105","author":"Cobo","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/ajcp\/105.5.567","article-title":"Remission of immune hemolytic anemia after removal of ovarian dermoid cyst: Case report","volume":"109","author":"Murad","year":"1982","journal-title":"Va Med"},{"key":"B46","doi-asserted-by":"publisher","first-page":"e15259","DOI":"10.1097\/MD.0000000000015259","article-title":"Challenges in management of unusual acquired factor V deficiency: A case report","volume":"98","author":"Takemoto","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"B47","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.2169\/internalmedicine.55.6459","article-title":"Acquired factor V inhibitor","volume":"55","author":"Hirai","year":"2016","journal-title":"Intern Med"},{"key":"B48","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1002\/ajh.2830190410","article-title":"A case of factor V inhibitor","volume":"19","author":"Chong","year":"1985","journal-title":"Am J Hematol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"112","DOI":"10.4274\/balkanmedj.2017.0158","article-title":"Successful outcome of severe intra-cerebral bleeding associated with acquired factor V inhibition: Utilization of multiple therapeutic agents","volume":"35","author":"Andreadis","year":"2018","journal-title":"Balkan Med J"},{"key":"B50","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1097\/01.mbc.0000245297.64644.ee","article-title":"Platelet factor V supports hemostasis in a patient with an acquired factor V inhibitor, as shown by prothrombinase and tenase assays","volume":"17","author":"Perdekamp","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"key":"B51","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/ajh.21056","article-title":"Successful treatment with rituximab in a patient with an acquired factor V inhibitor","volume":"83","author":"Lebrun","year":"2008","journal-title":"Am J Hematol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1159\/000505770","article-title":"Plasma exchange as an initial treatment for severe bleeding induced by acquired factor V deficiency: A case report and mini literature review","volume":"144","author":"Yanagiya","year":"2021","journal-title":"Acta Haematol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1080\/08916934.2016.1214823","article-title":"Effect of therapeutic plasma exchange on immunoglobulins in myasthenia gravis","volume":"49","author":"Guptill","year":"2016","journal-title":"Autoimmunity"},{"key":"B54","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1002\/ajh.10420","article-title":"High-dose intravenous immunoglobulin treatment in two patients with acquired factor V inhibitors","volume":"74","author":"de Raucourt","year":"2003","journal-title":"Am J Hematol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"110","DOI":"10.3389\/fmed.2020.00110","article-title":"Sirolimus as rescue therapy for refractory\/relapsed immune thrombocytopenia: Results of a single-center, prospective, single-arm study","volume":"7","author":"Feng","year":"2020","journal-title":"Front Med (Lausanne)"},{"key":"B56","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1744-9987.2008.00618.x","article-title":"A case report of plasma exchange, steroids, mycophenolate mofetil and cyclophosphamide in acquired factor VIII inhibitors","volume":"12","author":"Rech","year":"2008","journal-title":"Ther Apher Dial"},{"key":"B57","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1055\/s-0037-1619780","article-title":"Successful long-time treatment with mycophenolate-mofetil in a child with acquired factor VIII inhibitor","volume":"32","author":"Wermes","year":"2012","journal-title":"Hamostaseologie"},{"key":"B58","doi-asserted-by":"publisher","first-page":"46","DOI":"10.11406\/rinketsu.60.46","article-title":"Recurrence of acquired factor V inhibitor after four years of remission","volume":"60","author":"Akashi","year":"2019","journal-title":"Rinsho Ketsueki"},{"key":"B59","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/s1590-8658(02)80098-6","article-title":"Spontaneous remission of autoimmune hepatitis during pregnancy","volume":"34","author":"Muratori","year":"2002","journal-title":"Dig Liver Dis"},{"key":"B60","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s00281-007-0072-5","article-title":"The remission of rheumatoid arthritis during pregnancy","volume":"29","author":"Ostensen","year":"2007","journal-title":"Semin Immunopathol"}],"container-title":["Pathology and Oncology Research"],"original-title":[],"link":[{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2023.1611250\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,2]],"date-time":"2023-06-02T04:30:45Z","timestamp":1685680245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.por-journal.com\/articles\/10.3389\/pore.2023.1611250\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,2]]},"references-count":60,"alternative-id":["10.3389\/pore.2023.1611250"],"URL":"https:\/\/doi.org\/10.3389\/pore.2023.1611250","relation":{},"ISSN":["1532-2807"],"issn-type":[{"value":"1532-2807","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,2]]},"article-number":"1611250"}}